HGHYX
Price
$48.67
Change
-$0.06 (-0.12%)
Updated
Jun 12 closing price
Net Assets
743.61M
VGHCX
Price
$195.73
Change
-$0.13 (-0.07%)
Updated
Jun 12 closing price
Net Assets
36.96B
Interact to see
Advertisement

HGHYX vs VGHCX

Header iconHGHYX vs VGHCX Comparison
Open Charts HGHYX vs VGHCXBanner chart's image
HGHYX vs VGHCX Comparison Chart in %
View a ticker or compare two or three
VS
HGHYX vs. VGHCX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHYX is a Buy and VGHCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 37B vs. HGHYX (744M). VGHCX pays higher dividends than HGHYX: VGHCX (1.10) vs HGHYX (0.00). HGHYX was incepted earlier than VGHCX: HGHYX (26 years) vs VGHCX (42 years). HGHYX (1.05) is less costly to investors than VGHCX (0.33). HGHYX (49.00) and VGHCX (47.00) have comparable annual turnover. VGHCX has a lower initial minimum investment than HGHYX: VGHCX (3000) vs HGHYX (250000). HGHYX annual gain was more profitable for investors over the last year : 17.25 vs. VGHCX (10.17). HGHYX return over 5 years is better than : -6.68 vs. VGHCX (-15.80).
HGHYXVGHCXHGHYX / VGHCX
Total Expense Ratio1.050.33318%
Annual Report Gross Expense Ratio1.050.33318%
Fund Existence26 years42 years-
Gain YTD-0.082-4.3212%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets744M37B2%
Annual Yield % from dividends0.001.10-
Returns for 1 year17.2510.17170%
Returns for 3 years10.71-8.84-121%
Returns for 5 years-6.68-15.8042%
Returns for 10 years35.39-3.37-1,051%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALPAX11.220.09
+0.81%
American Century Focused Lg Cap Val A
FRBRX188.370.97
+0.52%
Franklin Biotechnology Discovery R6
MXXVX38.360.11
+0.29%
Matthew 25
BMPEX26.580.06
+0.23%
Beck Mack + Oliver Partners
JHQPX34.680.01
+0.03%
JPMorgan Hedged Equity R5